Saw palmetto extract
Mwepụta nke saw palmetto bụ mpụta nke saw palmetto. Enwere ụfọdụ mgbakwunye ndị enwere ike iji na-agwọ hyperplasia prostatic na-adịghị mma, mana ọ nweghị ihe akaebe na-egosi na ọ bara uru maka gị..[1][2][3][4]
Ojiji na nyocha
[dezie | dezie ebe o si]A na-ejikarị Saw palmetto eme ihe dị ka mgbakwunye iji meziwanye mgbaàmà nke hyperplasia prostate benign (BPH) - nke a makwaara dị ka mmụba nke prostate gland - nke bụ ọnọdụ na-emekarị na ndị agadi nwoke.[1][2]. Ọrịa cancer prostate nwere ike ime ka ọnụ ọgụgụ stool mụbaa, ọ ga-ekwe omume ịmalite stool, stool adịghị adịgide ma ọ bụ kwụsị, dribving nke njedebe nke stool, na stool enweghị ike iwepụ kpamkpam..[5]
Saw palmetto wepụ ka amụrụ na ule ụlọ ọgwụ dịka ọgwụgwọ nke nwere ike ịgwọ ọrịa cancer prostate na ndị ikom nwere mgbaàmà nke usoro urinary metụtara BPH.[1][2] Dịka nke 2023, enweghi ihe akaebe sayensị zuru oke nke hụrụ na mpụta palmetto dị irè n'ịgwọ ọrịa kansa ma ọ bụ akara BPH. [2] [3] Nnyocha ọmụmụ 2023 chọpụtara na palmetto wepụ "nwere ntakịrị ma ọ bụ enweghị mmetụta na ndị ikom nwere mgbaàmà urinary tract dị ka mmụba prostate.". "[4]
Nnwale ụlọ ọgwụ nke 2016 nke saw palmetto wepụ (a na-akpọ Permixon) chọpụtara na mpụta ahụ dị irè n'ibelata mgbaàmà nke BPH ma e jiri ya tụnyere placebo..[6]
Ọgwụ ọdịnala
[dezie | dezie ebe o si]A na-eji Saw palmetto na ọgwụ ọdịnala na-agwọ ụkwara na nsogbu ndị ọzọ.[1]
Nlezianya na ihe mgbochi
[dezie | dezie ebe o si]Ụmụaka
[dezie | dezie ebe o si]A naghị atụ aro Saw palmetto maka ụmụaka na-erubeghị afọ 12 n'ihi na ọ nwere ike imetụta metabolism nke androgens na hormones estrogen..[7]
Ime ime na inye nwa ara
[dezie | dezie ebe o si]Saw palmetto wepụ nwere ike imetụta androgen na estrogen metabolism.[1][2] Ebe ọ bụ na ọ nweghị ihe mere ị ga-eji jiri saw palmetto kwụsị ịzụ nwa, ị kwesịrị ịma mgbe ị dị ime ma ọ bụ mgbe ị dị ime..[3]
Mgbochi nke ule PSA
[dezie | dezie ebe o si]E gosiputara na saw palmetto na-ebelata ọkwa PSA n'ime ọbara, hormone nke prostate na-emepụta nke na-arụ ọrụ dị ka ihe nrịbama maka ọnụnọ ọrịa kansa prostate. Saw palmetto nwere ike ibelata ọkwa PSA, na-egbochi nsonaazụ ule.[8]
Mmekọrịta
[dezie | dezie ebe o si]Ihe a na-ewepụta na Saw palmetto nwere mmekọrịta ya na ọgwụ ndị ọzọ.[1]Mgbe ejiri ya na ọgwụ mgbochi ọbara ma ọ bụ ọgwụ mgbochi platelet, ihe a na-ewepụta na palmetto nwere ike ịbawanye ihe ize ndụ nke ọbara ọgbụgba site n'ịkwalite anticoagulation ma ọ bụ mmetụta mgbochi platelets.[1] Ihe atụ ụfọdụ nke ọgwụ mgbochi ọbara na ọgwụ mgbochi platelet gụnyere aspirin, clopidogrel, ọgwụ mgbochi mgbu na-abụghị steroid (NSAIDs) , na warfarin.[3]
Ihe odide
[dezie | dezie ebe o si]- ↑ 1.0 1.1 Saw palmetto. National Center for Complementary and Integrative Health, US National Institutes of Health (1 May 2020). Retrieved on 5 October 2020. Kpọpụta njehie: Invalid
<ref>tag; name "nih-ods" defined multiple times with different content - ↑ Spotlight on saw palmetto: What the science says. NCCIH Clinical Digest for Health Professionals, National Center for Complementary and Integrative Health, US National Institutes of Health (1 May 2020). Retrieved on 5 October 2020.
- ↑ 3.0 3.1 3.2 Saw palmetto. Drugs.com (30 November 2022). Retrieved on 12 June 2023.
- ↑ 4.0 4.1 Franco (2023-06-22). "Serenoa repens for the treatment of lower urinary tract symptoms due to benign prostatic enlargement". The Cochrane Database of Systematic Reviews 2023 (6): CD001423. DOI:10.1002/14651858.CD001423.pub4. ISSN 1469-493X. PMID 37345871. Kpọpụta njehie: Invalid
<ref>tag; name ":0" defined multiple times with different content - ↑ Benign prostatic hyperplasia. Mayo Clinic (2 March 2019). Retrieved on 5 October 2020.
- ↑ Novara (2016). "Efficacy and safety of hexanic lipidosterolic extract of Serenoa repens (Permixon) in the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia: Systematic review and meta-analysis of randomized controlled trials". European Urology Focus 2 (5): 553–561. DOI:10.1016/j.euf.2016.04.002. PMID 28723522.
- ↑ Fructus Serenoae Repentis. WHO Monographs on Selected Medicinal Plants. World Health Organization. Archived from the original on June 16, 2009. Retrieved on 29 October 2014.
- ↑ Murugusundram (2009). "Serenoa Repens: Does It have Any Role in the Management of Androgenetic Alopecia?". Journal of Cutaneous and Aesthetic Surgery 2 (1): 31–32. DOI:10.4103/0974-2077.53097. ISSN 0974-2077. PMID 20300369.